Cutaquig 165 mg/mL (immunoglobulin G SOLUTION) 165 mg/mL

Cutaquig 165 mg/mL is a subcutaneous immunoglobulin G solution used to treat immune deficiencies. This product, manufactured by Pfizer Laboratories, helps support the immune system in individuals with primary immunodeficiency.

Strength

165 mg/mL

Pack Size

1 VIAL, GLASS in 1 CARTON (0069-1476-02) / 12 mL in 1 VIAL, GLASS (0069-1476-01)

Manufacturer / TM Owner

Pfizer Laboratories Div Pfizer Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Cutaquig 165 mg/mL is primarily used for the treatment of primary immunodeficiency disorders. This medication helps to replace the antibodies that are missing or not functioning properly in the body. It is often prescribed for individuals who have difficulty fighting infections due to low levels of immunoglobulin G. The solution is administered subcutaneously, providing a convenient and effective method of delivery.

Side Effects

Common effects of Cutaquig 165 mg/mL may include redness, swelling, or itching at the injection site. Some individuals may also experience mild headaches or fatigue. These effects are generally temporary and should subside as the body adjusts to the medication. If any severe or persistent effects occur, it is important to consult a healthcare provider.

Precautions & Warnings

Cutaquig 165 mg/mL should be handled with care to ensure proper administration. The solution should be stored at the appropriate temperature and protected from light. It is important to follow the instructions provided by a healthcare provider for the correct use and disposal of the medication. Always check the expiration date before use.

Avoid Interactions

Cutaquig 165 mg/mL may interact with certain medications or substances. It is important to inform a healthcare provider about all current medications, including over-the-counter drugs and supplements, before starting treatment. Alcohol and other substances may also affect the effectiveness of the medication. Always consult a healthcare provider for personalized advice.

Frequently Asked Questions

Cutaquig 165 mg/mL is used to treat primary immunodeficiency disorders by replacing missing or non-functioning antibodies.

Cutaquig 165 mg/mL is administered subcutaneously, typically by a healthcare provider or trained individual.

Common effects may include redness, swelling, or itching at the injection site, as well as mild headaches or fatigue.

It is important to consult a healthcare provider about all current medications before starting Cutaquig 165 mg/mL to avoid potential interactions.

Cutaquig 165 mg/mL should be stored at the appropriate temperature and protected from light. Always check the expiration date before use.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.